Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Dimension is a venture capital firm founded in March 2022, headquartered in New York and San Francisco. The firm focuses on the intersection of technology and life sciences, aiming to partner with entrepreneurs to transform the trajectory of life on earth through innovative solutions in biotech and technology. Dimension has launched two funds, with the second fund, Dimension II, closing at $500 million in December 2024, oversubscribed against a $400 million target. The firm has quickly established a portfolio of approximately 20 companies since its inception.
The team at Dimension consists of experienced professionals with backgrounds in leading venture capital firms. Notable team members include Adam Goulburn, PhD, Nan Li, and Zavain Dar, all of whom have extensive experience in the venture capital space. The firm actively engages with its portfolio companies and the broader community through various channels, including blogs, newsletters, and podcasts, sharing insights on the latest developments in technology and life sciences.
Dimension's rapid growth and the successful fundraising of its second fund reflect strong confidence from limited partners in its investment thesis and portfolio performance. The firm is well-positioned to continue its impact in the biotech and technology sectors.
Dimension invests in companies at the intersection of technology and life sciences, specifically targeting sectors such as biotech platforms, software infrastructure, lab tools and instruments, clinical development, manufacturing and commercialization, and machine learning and artificial intelligence. The firm is flexible in its investment approach, engaging with startups at various stages, including pre-seed, seed, seed-plus, Series A, Series B, and Series C.
The firm seeks to partner with entrepreneurs who are innovating in these sectors, focusing on companies that leverage computational tools and AI to transform drug development and healthcare solutions. Dimension's investment strategy emphasizes the importance of founder-centric partnerships, allowing for tailored support and resources to help portfolio companies thrive. The firm is particularly interested in startups that demonstrate a strong potential for growth and impact in their respective fields.
Dimension's portfolio includes a diverse range of companies that exemplify its focus on the intersection of technology and life sciences. Notable portfolio companies include:
Dimension's portfolio reflects its commitment to supporting innovative solutions in biotech and technology, with a strong emphasis on companies that utilize AI and computational tools to advance drug discovery and healthcare.
Adam Goulburn, PhD - Founder & Managing Partner. Adam has a background as a General Partner at Lux Capital, where he focused on investments in technology and life sciences. He holds a PhD and brings extensive expertise in venture capital and scientific research.
Nan Li - Founder & Managing Partner. Nan previously served as a General Partner at Obvious Ventures, where she specialized in early-stage investments in technology and healthcare. Her experience includes a strong focus on supporting innovative startups.
Zavain Dar - Founder & Managing Partner. Zavain also comes from Lux Capital, where he was a General Partner. He has a proven track record in identifying and supporting high-potential startups in the biotech and technology sectors.
Simon Barnett - Research Director. Simon has a background in research and analysis, providing insights that inform Dimension's investment strategy and portfolio management.
To pitch Dimension, founders should use the preferred channel of their website at dimensioncap.com or email at contact@dimensioncap.com. It is essential to include a comprehensive deck that outlines the business model, market opportunity, and team background. Dimension appreciates detailed presentations that clearly convey the startup's vision and potential for impact.
Response times may vary, but founders can expect timely feedback on their submissions. Warm introductions are encouraged, as they can enhance the likelihood of a favorable review.
As of March 2026, Dimension is in the process of fundraising for its third fund, targeting approximately $700 million. This follows the successful closing of Dimension II at $500 million in December 2024, which was oversubscribed against a $400 million target. The firm has rapidly scaled its operations, establishing a portfolio of around 20 companies since its founding in 2022.
Recent investments include notable companies such as Chai Discovery, Automata, and Kaleidoscope Bio, reflecting Dimension's commitment to supporting innovative solutions in biotech and technology. The firm continues to engage with industry leaders and the community through various events and discussions, sharing insights on the latest trends and developments in the sectors it invests in.
What are Dimension's investment criteria?
Dimension invests in companies at the intersection of technology and life sciences, focusing on sectors such as biotech, AI, and healthcare. The firm targets various stages of development, from pre-seed to Series C.
How can I apply or pitch to Dimension?
Founders can pitch Dimension through their website at dimensioncap.com or via email at contact@dimensioncap.com. It is recommended to include a detailed deck outlining the business model, market opportunity, and team background.
What makes Dimension different from other venture capital firms?
Dimension focuses specifically on the convergence of technology and life sciences, providing tailored support and resources to portfolio companies. The firm emphasizes a founder-centric partnership model, allowing for deeper engagement with entrepreneurs.
What is Dimension's geographic scope?
Dimension invests globally, with a particular focus on the United States. The firm seeks opportunities in various markets that align with its investment thesis.
What is Dimension's post-investment involvement like?
Dimension actively engages with its portfolio companies through insights, updates, and community events. The firm provides resources and support to help companies navigate challenges and scale effectively.
What are the fund sizes and check sizes Dimension typically invests?
Dimension's current fund, Dimension II, has a size of $500 million. While specific check sizes are not disclosed, the firm invests across various stages, indicating flexibility in its investment amounts.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.